Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

GMP production of [18F]FDOPA and issues concerning its quality analyses as in USP "Fluorodopa F 18 Injection".

Kao CH, Hsu WL, Xie HL, Lin MC, Lan WC, Chao HY.

Ann Nucl Med. 2011 Jun;25(5):309-16. doi: 10.1007/s12149-010-0463-x. Epub 2011 Feb 23.

PMID:
21344169
3.
4.

18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.

Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW.

J Nucl Med. 2009 Apr;50(4):513-9. doi: 10.2967/jnumed.108.058396. Epub 2009 Mar 16.

5.

18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.

Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W.

Eur J Radiol. 2009 Aug;71(2):242-8. doi: 10.1016/j.ejrad.2008.04.018. Epub 2008 May 29.

PMID:
18511228
6.

Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.

Tripathi M, Sharma R, D'Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A.

Clin Nucl Med. 2009 Dec;34(12):878-83. doi: 10.1097/RLU.0b013e3181becfe0.

PMID:
20139821
7.

Current good manufacturing practice for positron emission tomography drugs.

Food and Drug Administration, HHS.

Fed Regist. 2009 Dec 10;74(236):65409-36.

8.

6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.

DeJesus OT, Haaparanta M, Solin O, Nickles RJ.

Brain Res. 2000 Sep 15;877(1):31-6.

PMID:
10980240
9.

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

Cumming P, Léger GC, Kuwabara H, Gjedde A.

J Cereb Blood Flow Metab. 1993 Jul;13(4):668-75.

PMID:
8314919
10.

An efficient and aseptic preparation of "sodium fluoride ((18)F) injection" in a GMP compliant facility.

Kao CH, Hsu WL, Kao PF, Lan WC, Xie HL, Lin MC, Chao HY.

Ann Nucl Med. 2010 Apr;24(3):149-55. doi: 10.1007/s12149-010-0343-4. Epub 2010 Feb 23.

PMID:
20177835
11.

Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.

Endres CJ, DeJesus OT, Uno H, Doudet DJ, Nickles JR, Holden JE.

Front Biosci. 2004 Jan 1;9:505-12.

PMID:
14766386
12.
13.

Plasma L-[18F]6-fluorodopa input function: a simplified method.

Chan GL, Morrison KS, Holden JE, Ruth TJ.

J Cereb Blood Flow Metab. 1992 Sep;12(5):881-4.

PMID:
1506454
14.

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

Huang SC, Yu DC, Barrio JR, Grafton S, Melega WP, Hoffman JM, Satyamurthy N, Mazziotta JC, Phelps ME.

J Cereb Blood Flow Metab. 1991 Nov;11(6):898-913.

PMID:
1939385
15.

Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.

Chan GL, Doudet DJ, Dobko T, Hewitt KA, Schofield P, Pate BD, Ruth TJ.

Life Sci. 1995;56(21):1759-66.

PMID:
7739350
16.

Production at the Curie level of no-carrier-added 6-18F-fluoro-L-dopa.

Libert LC, Franci X, Plenevaux AR, Ooi T, Maruoka K, Luxen AJ, Lemaire CF.

J Nucl Med. 2013 Jul;54(7):1154-61. doi: 10.2967/jnumed.112.112284. Epub 2013 May 8.

17.

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

Melega WP, Grafton ST, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

J Cereb Blood Flow Metab. 1991 Nov;11(6):890-7.

PMID:
1939384
18.

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.

Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P.

J Cereb Blood Flow Metab. 2005 Jul;25(7):807-19.

PMID:
15729292
19.

Automated production at the curie level of no-carrier-added 6-[(18)F]fluoro-L-dopa and 2-[(18)F]fluoro-L-tyrosine on a FASTlab synthesizer.

Lemaire C, Libert L, Franci X, Genon JL, Kuci S, Giacomelli F, Luxen A.

J Labelled Comp Radiopharm. 2015 Jun 15;58(7):281-90. doi: 10.1002/jlcr.3291. Epub 2015 May 26.

PMID:
26011311
20.

The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.

Hoffman JM, Melega WP, Hawk TC, Grafton SC, Luxen A, Mahoney DK, Barrio JR, Huang SC, Mazziotta JC, Phelps ME.

J Nucl Med. 1992 Aug;33(8):1472-7.

Supplemental Content

Support Center